Page 6 of 6 FirstFirst 123456
Results 51 to 60 of 60

Thread: Update on Geron

  1. #51

    Is this new?

    http://clinicaltrials.gov/ct2/show/N...%2F2011&rank=1

    Is this an example of one door closing while another opens?

  2. #52
    I can understand his comments, it's all just so frusterating.
    "Life is about how you
    respond to not only the
    challenges you're dealt but
    the challenges you seek...If
    you have no goals, no
    mountains to climb, your
    soul dies".~Liz Fordred

  3. #53
    Terribly frustrating! But, comments like that wouldn't help sway young biotechs to enter the field and work on SCI. They'll do a double take and enter safer fields like cancer, HIV, etc...(which many already do)

    I just don't see cancer, HIV, ALS, SMA organizations making statements in the Washington Post like that when one of their promising biotechs aren't successful in a clinical trial treatment or they go totally under and out of business.

    Why would the general public want to donate to CDRF if SCI folks feel like lab rats when all the proposed treatments absolutely have to go through one of these clinical trials? It makes the general public think we don't want any clinical trials because we'll feel like lab rats. I was saddened by that kind of comment. Will that help donations for research or future trials? Seriously???? With a one star financial rating at CharityNavigator, I don't think I'd be making statements like that! Whew!
    Last edited by GRAMMY; 11-17-2011 at 11:24 PM.

  4. #54
    Quote Originally Posted by Curt Leatherbee View Post
    I can understand his comments, it's all just so frusterating.
    Did you think that GRN OPC1 was directly going to help us get out of w/c?

    I am disappointed that they stopped the trial, but I don't think it is a big deal for us.

    Let's not forget they got the FDA approval and they did 4 people. That's a big positive deal IMO.

    Hans Keirstead, for example, has the way open for his next trial with hESC derived cells thanks to Geron.

    It seems to me Denny is missing that. If he were just "one of us with SCI" it could be OK, but if he is a member of the CDRF board, that's not ok IMO.

    Paolo
    In God we trust; all others bring data. - Edwards Deming

  5. #55
    http://sciencedude.ocregister.com/20...-trial/159883/

    Geron Corp. shuts down world’s first stem-cell trial

    A culture of human embryonic stem cells. Photo courtesy UC Irvine.

    Geron Corp. is shutting down the world’s first patient trial of a treatment involving human embryonic stem cells, citing lack of funding and economic difficulties.
    The company’s decision leaves a doubtful future for clinical trials of the spinal-cord injury treatment, developed by researchers at UC Irvine.
    Hans Keirstead, who developed the treatment along with UCI researcher Gabriel Nistor, said he is exploring alternative funding to continue the trials.
    Neither was involved in Geron’s clinical trial.
    UC Irvine stem-cell researcher Hans Keirstead. Register photo by Leonard Ortiz.

    Geron recently reported that patients had completed the first year of a safety trial of the treatment with no adverse effects.
    But with a potential pool of only about 6,000 patients per year, the trial could not acquire enough funding to continue, Keirstead said Wednesday.
    “In a nutshell, the small market size could not support the cost of development,” Keirstead said. “That is a fear that the spinal cord community has had for years, and now it clearly manifests itself.”
    Geron said it also is laying off 66 full-time employees.
    The treatment is for acute spinal cord injuries, less than 14 days old. Neural cells derived from human embryonic stem cells are injected into the site of the injury.
    The trial underway so far was only to check the safety of the procedure; a trial to measure its effectiveness was expected to follow.
    Geron announced in October that patients involved in the trial experienced no ill effects from the treatment itself, although there were a few “mild” adverse reactions to a drug used to suppress the immune system.
    And one of the patients, Timothy Atchison of Alabama, came forward to report that he had experienced sensation in his legs after the treatment, although his statement was not scientifically verified.
    The treatment has the potential to reverse paralysis from such injuries, and has succeeded in doing so in laboratory rats.
    “I’m really disheartened for the patients,” Keirstead said. “All I ever wanted to do was develop treatments for spinal cord injuries and other diseases. This is a serious blow to the treatment.”
    Still, he said he was optimistic that alternative funding could be found and the trials could go forward.
    “I don’t think this is the end of the road for this trial,” he said. “I think it’s a hurdle rather than a barrier. We’ll get over it.”
    Moving the treatment beyond the United States could increase the number of potential patients and reduce costs, he said.
    “I predict this will move offshore,” he said.
    Last edited by GRAMMY; 11-17-2011 at 11:28 PM.

  6. #56
    Hope :

    1. confident desire: a feeling that something desirable is likely to happen
    "The research offers hope to sufferers."


    2. likelihood of success: a chance that something desirable will happen or be possible
    "There's not much hope that things will improve."


    3. wish or desire: something that somebody wants to have or do or wants to happen or be true
    "My hope is that she will change her mind."


    4. source of success: somebody or something that seems likely to bring success or relief
    "We have to do this, it's our only hope."


    5. trust: a feeling of trust
    Last edited by jhope; 11-26-2011 at 02:56 PM.

  7. #57
    Quote Originally Posted by GRAMMY View Post
    http://sciencedude.ocregister.com/20...-trial/159883/

    Geron Corp. shuts down world’s first stem-cell trial

    A culture of human embryonic stem cells. Photo courtesy UC Irvine.

    Geron Corp. is shutting down the world’s first patient trial of a treatment involving human embryonic stem cells, citing lack of funding and economic difficulties.
    The company’s decision leaves a doubtful future for clinical trials of the spinal-cord injury treatment, developed by researchers at UC Irvine.
    Hans Keirstead, who developed the treatment along with UCI researcher Gabriel Nistor, said he is exploring alternative funding to continue the trials.
    Neither was involved in Geron’s clinical trial.
    UC Irvine stem-cell researcher Hans Keirstead. Register photo by Leonard Ortiz.
    bbm

    Bless this guy for perservering in spite of the setback! Where the heck is Bill Gates when we need him??!

  8. #58
    Quote Originally Posted by KYLady View Post
    Where the heck is Bill Gates when we need him??!
    He is vaccinating children in impoverished 3rd world countries against TB and malaria, mostly

  9. #59
    Quote Originally Posted by paolocipolla View Post
    Did you think that GRN OPC1 was directly going to help us get out of w/c?

    I am disappointed that they stopped the trial, but I don't think it is a big deal for us.

    Let's not forget they got the FDA approval and they did 4 people. That's a big positive deal IMO.

    Hans Keirstead, for example, has the way open for his next trial with hESC derived cells thanks to Geron.

    It seems to me Denny is missing that. If he were just "one of us with SCI" it could be OK, but if he is a member of the CDRF board, that's not ok IMO.

    Paolo
    Paolo: A 5th individual was implanted at Stanford 2 days after the Genron announcement. The individual had entered an agreement with Genron prior to their shutting down the trial.

    It is impt for people to note that Genron is continuing to study the 5 people involved.
    Every day I wake up is a good one

  10. #60
    Quote Originally Posted by cheesecake View Post
    Paolo: A 5th individual was implanted at Stanford 2 days after the Genron announcement. The individual had entered an agreement with Genron prior to their shutting down the trial.

    It is impt for people to note that Genron is continuing to study the 5 people involved.
    Sure it is great that a 5th individual has been implanted, that will add statiatical strenght to the outcome data.
    I have also stated in a previous post that I believe we have to thank Geron for what they did. Even if the 5 patients treated do not recover but "just" don't show side effects it would still be a great progress IMO.

    Paolo
    In God we trust; all others bring data. - Edwards Deming

Similar Threads

  1. Geron OPC-1 update - Investor speech
    By swharris in forum Cure
    Replies: 1
    Last Post: 02-09-2011, 07:30 PM
  2. geron
    By cdurfee99 in forum Cure
    Replies: 6
    Last Post: 10-02-2009, 08:08 PM
  3. Replies: 0
    Last Post: 06-23-2005, 09:24 AM
  4. Replies: 1
    Last Post: 04-04-2003, 12:24 PM
  5. Replies: 0
    Last Post: 03-12-2002, 12:02 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •